William Blair Issues Pessimistic Outlook for BEAM Earnings
Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) – Research analysts at William Blair reduced their Q2 2025 earnings per share estimates for Beam Therapeutics in a report released on Tuesday, May 6th. William Blair analyst S. Corwin now anticipates that the company will earn ($1.01) per share for the quarter, down from their previous forecast […]
Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) – Research analysts at William Blair reduced their Q2 2025 earnings per share estimates for Beam Therapeutics in a report released on Tuesday, May 6th. William Blair analyst S. Corwin now anticipates that the company will earn ($1.01) per share for the quarter, down from their previous forecast […]
